Delivery Order SPE2DR25D1110-SPE2DR26F12VX
- Not listed
- The Defense Logistics Agency awarded a $1,379.80 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,449.50 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used for immunization against Salmonella typhi, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes valued at $1,379.80 with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with performance scheduled for completion by July 25, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used by the Department of Defense for military personnel and beneficiaries requiring...
- The Defense Logistics Agency awarded a $44,212.72 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitive award, which has no set-aside designation, is scheduled for completion by August 18, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used for immunization purposes, representing part of the federal government's pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,899 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid conjugate vaccine commonly used for military personnel and federal...
- The Defense Logistics Agency awarded a $13,798.00 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 20, 2025. This firm fixed-price contract, awarded on August 19, 2025, utilizes a competitive delivery order mechanism with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $13,798.00 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 20, 2025, with a completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. TYPHIM VI is a typhoid vaccine used for immunization against typhoid fever, supporting military and federal healthcare requirements. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $31,114.49 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 5, 2025, with completion scheduled for September 8, 2025. This competitively awarded, firm fixed-price delivery order was executed without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, reflecting the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $7,335.04 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine administered in pre-filled syringes, and this delivery...
- The Defense Logistics Agency awarded a $3,449 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on October 15, 2025, with completion targeted for October 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, reflecting the broader pharmaceutical and medical supply portfolio that...
- SPE2DR25D1110Indefinite Delivery Contract
- SPE2DR25D1110-SPE2DR26F12VXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes with a ceiling value of $9,930.40 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of October 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used for immunization purposes, and this delivery order fulfills military healthcare supply needs through the federal pharmaceutical procurement process. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems globally. The company's extensive federal contract portfolio demonstrates its capability to meet diverse medical procurement requirements across multiple therapeutic domains and product categories through competitively awarded agreements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 10/27/25 |